Erratum: Monthly ranibizumab for nonproliferative macular telangiectasia type 2: A 12-month prospective study (American Journal of Ophthalmology (2011) 151:5 (876-886))

P. Charbel Issa, R. P. Finger, K. Kruse, S. Baumüller, H. P.N. Scholl, F. G. Holz

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Number of pages1
JournalAmerican journal of ophthalmology
Volume152
Issue number1
DOIs
StatePublished - Jul 1 2011

ASJC Scopus subject areas

  • Ophthalmology

Cite this